Engineering Biomimetic Nanoparticles through Extracellular Vesicle Coating in Cancer Tissue Models
-
Published:2023-12-07
Issue:24
Volume:13
Page:3097
-
ISSN:2079-4991
-
Container-title:Nanomaterials
-
language:en
-
Short-container-title:Nanomaterials
Author:
Quiñonero Gema1, Gallo Juan2ORCID, Carrasco Alex1, Samitier Josep134ORCID, Villasante Aranzazu13ORCID
Affiliation:
1. Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain 2. Advanced Magnetic Theranostic Nanostructures Laboratory, International Iberian Nanotechnology Laboratory (INL), 4715-330 Braga, Portugal 3. Department of Electronic and Biomedical Engineering, University of Barcelona, 08028 Barcelona, Spain 4. Biomedical Research Networking Center in Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), 28029 Madrid, Spain
Abstract
Using nanoparticles (NPs) in drug delivery has exhibited promising therapeutic potential in various cancer types. Nevertheless, several challenges must be addressed, including the formation of the protein corona, reduced targeting efficiency and specificity, potential immune responses, and issues related to NP penetration and distribution within 3-dimensional tissues. To tackle these challenges, we have successfully integrated iron oxide nanoparticles into neuroblastoma-derived extracellular vesicles (EVs) using the parental labeling method. We first developed a tissue-engineered (TE) neuroblastoma model, confirming the viability and proliferation of neuroblastoma cells for at least 12 days, supporting its utility for EV isolation. Importantly, EVs from long-term cultures exhibited no differences compared to short-term cultures. Concurrently, we designed Rhodamine (Rh) and Polyacrylic acid (PAA)-functionalized magnetite nanoparticles (Fe3O4@PAA-Rh) with high crystallinity, purity, and superparamagnetic properties (average size: 9.2 ± 2.5 nm). We then investigated the internalization of Fe3O4@PAA-Rh nanoparticles within neuroblastoma cells within the TE model. Maximum accumulation was observed overnight while ensuring robust cell viability. However, nanoparticle internalization was low. Taking advantage of the enhanced glucose metabolism exhibited by cancer cells, glucose (Glc)-functionalized nanoparticles (Fe3O4@PAA-Rh-Glc) were synthesized, showing superior cell uptake within the 3D model without inducing toxicity. These glucose-modified nanoparticles were selected for parental labeling of the TE models, showing effective NP encapsulation into EVs. Our research introduces innovative approaches to advance NP delivery, by partially addressing the challenges associated with 3D systems, optimizing internalization, and enhancing NP stability and specificity through EV-based carriers. Also, our findings hold the promise of more precise and effective cancer therapies while minimizing potential side effects.
Funder
Biomedical Research Networking (CIBER), Spain Plan de Recuperación, Transformación y Resiliencia Plan Complementario de Biotecnología aplicada a la salud Spanish Association Against Cancer Association of Families and Friends of Children with Neuroblastoma Spanish National R + D + i
Subject
General Materials Science,General Chemical Engineering
Reference25 articles.
1. Neuroblastoma;Matthay;Nat. Rev. Primers,2016 2. Xu, M., Han, X., Xiong, H., Gao, Y., Xu, B., Zhu, G., and Li, J. (2023). Cancer Nanomedicine: Emerging Strategies and Therapeutic Potentials. Molecules, 28. 3. Engineering precision nanoparticles for drug delivery;Mitchell;Nat. Rev. Drug Discov.,2020 4. The protein corona from nanomedicine to environmental science;Mahmoudi;Nat. Rev. Mater.,2023 5. Ernst, L., Casals, E., Italiani, P., Boraschi, D., and Puntes, V. (2021). The Interactions between Nanoparticles and the Innate Immune System from a Nanotechnologist Perspective. Nanomaterials, 11.
|
|